戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s an established downstream target promoter (tenascin-c).
2 ctor SOX4 and extracellular matrix component tenascin C.
3 ascular endothelial growth factor (VEGF) and tenascin C.
4 eractions between the aggrecan G3 domain and tenascin-C.
5 ggrecan as well as articular markers such as tenascin-C.
6 ed the presence of the target protein, human tenascin-C.
7 rite outgrowth by itself and also as part of tenascin-C.
8 ion of syndecan-4 circumvents the effects of tenascin-C.
9 extracellular matrix ligands osteopontin and tenascin-C.
10 e other alpha9beta1 ligands, osteopontin and tenascin-C.
11 een control cells and cells transfected with tenascin-C.
12 duction of brain natriuretic peptide but not tenascin-C.
13 xtracellular matrix proteins osteopontin and tenascin-C.
14  all three alternatively spliced isoforms of tenascin-C.
15 tical for neutrophil migration on VCAM-1 and tenascin-C.
16 lobulin, Rab geranylgeranyl transferase, and tenascin-C.
17 lfonate significantly inhibited induction of tenascin-C.
18  that hair cells supply at least part of the tenascin-C.
19 ding to the alternatively spliced regions of tenascin-C.
20 n AP chimera, interacts strongly with native tenascin-C.
21  N-CAM, tenascin-C, FGF-5, or both N-CAM and tenascin-C.
22 action with the proteoglycan binding site on tenascin-C.
23 oximately 12 nM) as to native or recombinant tenascin-C.
24 on of proliferating cell nuclear antigen and tenascin-C.
25 ased EMT protein markers, SMA, vimentin, and tenascin-c.
26 levels under the control of the promoter for tenascin-C.
27 egulation of anti-adhesive molecules such as tenascin-C.
28 pha9beta1-mediated adhesion and migration on tenascin-C.
29  (5.8-fold versus control, P:<0.05, n=3) and tenascin-C (7.0-fold, P:<0.02) mRNA expression by strain
30                                              Tenascin-C, a developmentally regulated matrix protein,
31                                              Tenascin-C, a matrix protein induced upon tissue damage
32  mechanical strain on the gene expression of tenascin-C, a prominent extracellular molecule in active
33                                 Induction of tenascin-C, a proproliferative and promigratory extracel
34              Syndecan-4 is also required for tenascin-C action.
35 Inhibition of syndecan-4 function suppresses tenascin-C activity and overexpression of syndecan-4 cir
36                                              Tenascin C-adhering cells remained round, whereas they s
37  by immunocytochemistry, the distribution of tenascin-C along neural growth pathways in the developin
38                              The presence of tenascin-C along the growth routes of nerve fibers, part
39 stains in the rodent heart demonstrated that tenascin-C also colocalizes with EPCs homing to sites of
40  and media-lumen ratio and overexpression of tenascin C, an extracellular matrix glycoprotein that co
41  (EGFR) found within the EGF-like repeats of tenascin-C, an antiadhesive matrix component present dur
42                                              Tenascin-C, an extracellular matrix protein involved in
43                                        CD44, tenascin C and fibrillin-1 mRNA levels were reduced by 4
44 s such as SPARC, thrombospondin 1 and 2, and tenascin C and X subserve important functions in extrace
45 ie, production of collagen, fibronectin, and tenascin-C and accumulation of myofibroblasts).
46 ronment consisting of the highly upregulated tenascin-C and chondroitin sulfate proteoglycans (CSPGs)
47 Newly characterized Ets target genes such as tenascin-C and collagen type I suggest their role in dis
48 ectin type III repeats 1-2, A, B, and 6-8 of tenascin-C and fibronectin type III repeats 1-2 and 6-8
49 ith matrices representative of transitional (tenascin-C and fibronectin) and differentiated environme
50 nts of this dynamic matrix, hyaluronic acid, tenascin-C and fibronectin, differentially direct cellul
51 ograft model of advanced human osteosarcoma, tenascin-C and its receptor integrin alpha9beta1 were de
52                                  Full length tenascin-C and longer fragments containing this repeat d
53 hesion assays showed the interaction between tenascin-C and newborn cells to be predominantly RGD-ind
54 t binding of alpha9beta1-expressing cells to tenascin-C and osteopontin, respectively, had no effect
55         The functional importance of stromal Tenascin-C and S100A4(+) fibroblast-derived VEGF-A in me
56                                 In this way, tenascin-C and syndecan-4 work together to control fibro
57 d in the developing brain: the glycoproteins tenascin-C and tenascin-R and the chondroitin sulfate pr
58 extracellular domain of the beta2 subunit to tenascin-C and tenascin-R in vitro.
59 ls to extracellular matrix molecules such as tenascin-C and tenascin-R may play a crucial role in loc
60 sion proteins containing various segments of tenascin-C and tenascin-R were purified, digested with t
61 eract with the extracellular matrix proteins tenascin-C and tenascin-R.
62  binds to the extracellular matrix molecules tenascin-C and tenascin-R.
63 ta1- and FGF-2-induced de novo expression of tenascin-C and the downregulation of alpha3(IV) collagen
64  alpha7beta1 integrin mediates a response to tenascin-C and the first to demonstrate a functional rol
65 M molecules and growth factors, particularly Tenascin-C and VEGF-A.
66 s for cell adhesion/motility (syndecan-4 and tenascin-C) and hyaluronan (HA) signaling.
67       Bone matrix markers (biglycan, COL1A1, tenascin C, and fibronectin) and low-density lipoprotein
68  (N-CAM), an extracellular matrix component, tenascin-C, and a soluble growth factor, fibroblast grow
69 hed with vascular endothelial growth factor, tenascin-C, and activated matrix metalloproteinase-9, fa
70 ether, these results demonstrate that N-CAM, tenascin-C, and FGF-5 are dispensable for major aspects
71 transitional matrix rich in hyaluronic acid, tenascin-C, and fibronectin controls muscle cell behavio
72                We could validate phosphacan, tenascin-C, and L1-CAM as major LeX carrier proteins pre
73 n, matrix metalloproteinases (MMPs) 2 and 9, tenascin-C, and osteopontin, revealed that MMP-9 and ten
74  vascular cell adhesion molecule 1 (VCAM-1), tenascin-C, and osteopontin.
75 lly expresses neural cell adhesion molecule, tenascin-C, and other molecules.
76 00 were induced >2.5-fold: cyclooxygenase-1, tenascin-C, and plasminogen activator inhibitor-1.
77                                        TSP1, tenascin-C, and SPARC induce the intermediate adhesive s
78 regulated matricellular proteins TSP1 and 2, tenascin-C, and SPARC.
79 tracellular matrix proteins, fibronectin and tenascin-C, and the basement membrane components, lamini
80  several MMPs, TGF-beta signaling molecules, Tenascin-C, and VEGF-A, while pro-fibrotic molecules, in
81               In addition, the expression of tenascin C, another marker of the mammary mesenchyme, is
82                                              Tenascin-C-AR modified cells aggregated to cells in a te
83  stem cell (HSC) mimics were modified with a tenascin-C-AR to improve the homing of HSC after an auto
84                                    Levels of tenascin-C are elevated in SSc skin biopsy samples, and
85 iated by the alternatively spliced region of tenascin-C are separable events that can be independentl
86 n alpha8 beta1-fibronectin, vitronectin, and tenascin-C-are not appropriately localized to mediate al
87 s performed and led to the identification of tenascin-C as a candidate protein.
88 valuate the contribution of the glycoprotein tenascin-c as a key mediator of smooth muscle cell growt
89     Together, our data highlight the role of tenascin-C as a microenvironmental regulator of cardiac
90                     Thus, we have identified tenascin-C as a novel endogenous activator of TLR4-media
91                       These results identify tenascin-C as an endogenous danger signal that is upregu
92       Our study revealed midkine, CYR61, and tenascin-C as endogenous substrates for KLK7.
93 the physiologically relevant presentation of tenascin-C as hexabrachion, and suggesting an increase i
94 lts show that trimers are an intermediate of tenascin-C assembly and that Cys-64 is essential for for
95  p21 loss, elevated NF-kappaB expression and tenascin C-associated rigidity, with p-Mypt1 inactivatio
96 ted epithelial cells with alpha9 integrin, a tenascin-C-binding integrin, led to a large increase in
97  adhesion modulatory proteins, fibulin-1 and tenascin-C, both of which bind to the C-terminal heparin
98 ype mice or mice with a targeted deletion of tenascin-C by assessing cell maturation, cytokine synthe
99 ha(v)beta(3), suggesting that fibrinogen and tenascin C C-terminal domains interact with alpha(v)beta
100                           We also found that tenascin C C-terminal fibrinogen-like domain specificall
101     Using live-cell imaging, we found softer tenascin-C-coated substrates significantly enhanced migr
102  cells preferentially migrated and colonized tenascin-C-coated trabecular bone xenografts in a novel
103                        In the spiral lamina, tenascin-C coexists in a region where nerve bundles arbo
104 f age, there were fewer condylar superficial tenascin-C/Col1-positive cells and more numerous apoptot
105 ges in netrin 4, fibroblast growth factor 2, tenascin C, collagen 1, meprin 1-alpha, and meprin 1-bet
106                              Total levels of tenascin C, collagen type XII, and CD44 mRNA were increa
107 top 10 results (collagen, type III, alpha-1; tenascin C; collagen, type VI, alpha-3; thrombospondin 2
108 ation of thick fibronectin fibrils, to which tenascin C colocalized.
109                               The effects of tenascin-C combined with its location around the wound b
110 PGE(2) but more PGI(2) and expressed reduced tenascin-C compared with wild-type cells.
111                                The region of tenascin-C containing only alternately spliced fibronect
112             We have found that the region of tenascin-C containing only alternately spliced fibronect
113 ons were observed only to short fragments of tenascin-C containing the third fibronectin type III rep
114                             We conclude that tenascin C contributes to the generation of a stem cell
115 ciated KLKs), whereas others (e.g. CYR61 and tenascin-C) could be digested by several KLKs.
116                                              Tenascin-C deficiency resulted in minor structural diffe
117                                              Tenascin C-deficient mice also have altered numbers of C
118 -C, and osteopontin, revealed that MMP-9 and tenascin-C demonstrated reduced expression both in vitro
119 nipin reduced the levels of collagen type I, tenascin C, elastin and versican.
120                   Select EGF-like repeats of tenascin-C elicited mitogenesis and EGFR autophosphoryla
121                                              Tenascin-C (encoded by Tnc) is an extracellular matrix g
122 ltured on osteo-mimetic surfaces coated with tenascin C exhibited enhanced adhesion and colony format
123                            Using portions of tenascin-C expressed as recombinant proteins in human fi
124        The permissive guidance cues of large tenascin-C expressed by cells were mapped to fnA-D.
125 C-AR modified cells aggregated to cells in a tenascin-C expressing stem cell niche model better than
126  a correlation of IL-17+ T cell numbers with tenascin C-expressing cells and MMP-9+ eosinophils was a
127  PGE(2) and augmentation of PGI(2) attenuate tenascin-C expression and vascular smooth muscle cell pr
128 showed both retention of alpha9 integrin and tenascin-C expression at the anterior stromal-epithelial
129                                              Tenascin-C expression begins with adventitial myofibrobl
130                           Among these cells, tenascin-C expression is most highly induced in activate
131      Suppression of GTPase activation allows tenascin-C expression to act as a regulatory switch to r
132                                              Tenascin-C expression, however, did not persist in this
133 nregulated both TGF-beta1- and FGF-2-induced tenascin-C expression, ROCK inhibition was found to down
134 pathologic remodeling with aberrant Prx1 and Tenascin-C expression.
135 eased proliferating cell nuclear antigen and tenascin-C expression.
136 after vascular injury, in part by regulating tenascin-C expression.
137 ons in homozygous mutant mice lacking N-CAM, tenascin-C, FGF-5, or both N-CAM and tenascin-C.
138 infant but not the adult DM was positive for tenascin-C, fibrillin-1, SPARC, and laminin-332.
139                   Here, we report that, like tenascin-C, fibulin-1 inhibits fibroblast spreading and
140 kers, including collagen types I and III and tenascin-C, fostered statistically significant cell alig
141 ey cellular regulators, such as EGFR, HSP70, Tenascin C, Frizzled-5, Patched-1, and Delta-like 1.
142 s indicated that mechanical strain increases tenascin-C gene transcription by activating nuclear fact
143 nents (fibrillar type I and III collagen and tenascin-C) had no effect.
144                                              Tenascin-C has been implicated in regulation of both neu
145 shown previously that a particular region of tenascin-C has powerful neurite outgrowth-promoting acti
146 ssibility that growth cone interactions with tenascin-C helps to guide nerve fibers in the cochlea.
147         Dendritic cells that did not express tenascin-C, however, produced lower levels of inflammato
148 show dynamic spatial and temporal changes in tenascin-C, hyaluronic acid, and fibronectin ECM distrib
149                                        Faint tenascin-C immunolabeling of normal hair cells, strong t
150   At the age when most neural growth ceases, tenascin-C immunoreactivity disappears.
151      Mg2+ increased newborn cell adhesion to tenascin-C in a concentration-dependent manner, whereas
152 s demonstrate that mechanical strain induces tenascin-C in cardiac myocytes through a nuclear factor-
153               To determine the importance of tenascin-C in cardiac neovascularization, we used an est
154 ted to bind to fibronectin, vitronectin, and tenascin-C in cell adhesion or neurite outgrowth assays.
155 diated induction of procollagen type III and tenascin-C in isolated cardiac fibroblasts was dependent
156 cts, interstitial deposition of collagen and tenascin-C in the remodeling myocardium was markedly red
157 ults illuminate how tumor cell deposition of tenascin-C in the tumor microenvironment promotes invasi
158 te how the extracellular matrix glycoprotein tenascin-C in the tumor microenvironment promotes invasi
159 aim of this study was to examine the role of tenascin-C in this cell type.
160       In contrast to their interactions with tenascin-C, in which binding was decreased by approximat
161 otion of neurite outgrowth by fnD as well as tenascin-C, indicating that this peptide sequence is fun
162 SCCs exhibited increased NF-kappaB and novel tenascin C, indicative of elevated rigidity; yet despite
163 n in vivo in mice, and addition of exogenous tenascin-C induces cytokine synthesis in explant culture
164 ia of individuals with rheumatoid arthritis, tenascin-C induces synthesis of proinflammatory cytokine
165                                Functionally, tenascin-C inhibits cardiac endothelial cell spreading a
166  including VEGF, IL-6, VEGF-C, HB-EGF, CTGF, tenascin C, integrin alpha5, and Eph receptor A2.
167                         Here, we report that tenascin C is expressed in the bone endosteum and is ass
168                                              Tenascin C is highly expressed in the SVZ, and transgeni
169 igands, implying that the RGD site in native tenascin-C is a cryptic binding site for this integrin,
170                                              Tenascin-C is a glycoprotein of the extracellular matrix
171                                              Tenascin-C is a large extracellular matrix glycoprotein
172                                              Tenascin-C is a large, multimeric extracellular matrix p
173             The extracellular matrix protein tenascin-C is a multidomain protein that regulates cell
174                         By embryonic day 16, tenascin-C is abundant on the pillar side of the inner h
175                                              Tenascin-C is an arthritogenic extracellular matrix glyc
176                                              Tenascin-C is an extracellular matrix molecule that driv
177                                              Tenascin-C is an extracellular matrix protein that regul
178                                 We show that tenascin-C is anti-adhesive for retinal pigmented epithe
179                     The inhibitory effect of tenascin-C is circumvented by downstream activation of R
180    This demonstrates for the first time that tenascin-C is essential for postnatal cardiac angiogenic
181                                              Tenascin-C is expressed in response to balloon injury.
182                                              Tenascin-C is expressed in the vessel wall after vascula
183                                              Tenascin-C is expressed transiently during wound repair
184 peptide sequence this integrin recognizes in tenascin-C is highly homologous to the sequence recogniz
185                  These data demonstrate that tenascin-C is important in DC-mediated polarization of T
186 position of the extracellular matrix protein tenascin-C is part of the reactive stroma response, whic
187                            Here we show that tenascin-C is produced by type-B cells and forms a layer
188        The extracellular matrix glycoprotein tenascin-C is widely expressed in the vertebrate central
189 , laminin, and nidogen, as well as the large tenascin-C isoform, fibronectin, and type I gelatin in v
190 of proangiogenic genes, such as osteopontin, tenascin C, KGF, angiopoietin, HIF-1alpha, and PDGFRbeta
191                                              Tenascin-C levels and tumor uptake were studied in a var
192                       In the organ of Corti, tenascin-C lines the neural pathways along pillar and De
193                         Here, we report that tenascin-C markedly altered cell phenotype on a three-di
194 , vimentin, discoidin domain receptor 2, and tenascin C, markers of fibroblasts and components of the
195              Cells surrounded by a fibrin-FN+tenascin-C matrix are unable to induce matrix contractio
196  to facilitate colonization, whereas stromal Tenascin-C may provide protection from apoptosis.
197 model and showed that unlike wild-type mice, tenascin-C-/- mice fail to vascularize cardiac allograft
198                           As with the intact tenascin-C molecule, adherent cells remained round, and
199 cated near the carboxyl-terminal part of the tenascin-C molecule.
200                    Mechanical strain induced tenascin-C mRNA (3.9 +/- 0.5-fold, p < 0.01, n = 13) and
201                                              Tenascin-C mRNA expression was detected in epithelial, s
202                           SMA, vimentin, and tenascin-c mRNAs were decreased by 60%, 40%, and 49%, re
203 A in metastasis was established by examining Tenascin-C null mice and transgenic mice expressing Cre
204                                    Moreover, tenascin-C-null mice displayed ablated levels of interle
205                 Dendritic cells derived from tenascin-C-null mice exhibited no defects in maturation;
206 NS and other organs have been found in adult tenascin-C-null mice, raising the question of whether th
207                  Despite multiple effects of tenascin-C on cell behaviour in culture, no structural a
208 ed by expressing an integrin that recognizes tenascin-C, one of the components of glial scar tissue,
209  rat aorta to investigate the interaction of tenascin-C or its various domains with these cells using
210 association of the alpha7beta1 integrin with tenascin-C peptides containing the VFDNFVLK sequence but
211 co-localizing with the fibrillar fibronectin/tenascin-C/periostin structures that characteristically
212                                    Truncated tenascin-C promoter-reporter assays using dominant negat
213 utonomous signaling mechanism explaining how tenascin-C promotes cancer cell migration in the tumor m
214                                              Tenascin-C promotes growth of axons if they express a te
215                 Intra-articular injection of tenascin-C promotes joint inflammation in vivo in mice,
216 as occurs in the presence of the ECM protein tenascin-C, promotes a motile phenotype; FAK and Rho sig
217  Analysis of human coronary thrombi revealed tenascin-C protein expression colocalized with the endot
218 RNA (3.9 +/- 0.5-fold, p < 0.01, n = 13) and tenascin-C protein in an amplitude-dependent manner but
219                           Cells on fibrin-FN+tenascin-C redistribute their actin to the cell cortex,
220 demonstrating the potential applicability of tenascin-C regions as therapeutic reagents.
221 ansgenic approach, we have demonstrated that tenascin-C regulates both cell proliferation and migrati
222 f the provisional matrix, we have found that tenascin-C regulates cell responses to a fibrin-FN matri
223 anding how the extracellular matrix molecule tenascin-C regulates neuronal growth.
224 se of MMPs was accompanied by an increase in tenascin-C release.
225 aling by competitive binding of fibulin-1 or tenascin-C represents a shared mechanism of adhesion mod
226 21-associated differentiation in wdSCCs; yet tenascin C retention in connective tissue extracellular
227 um channels on microtiter plates coated with tenascin-C revealed saturable and specific binding with
228  dorsal root ganglia regenerated through the tenascin-C-rich dorsal root entry zone into the dorsal c
229 (+)) preceded K14.ROCK(er)-mediated (p-Mypt1/tenascin C/rigidity) malignant conversion.
230     Of these, "FD" and "FV" are conserved in tenascin-C sequences derived from all the species availa
231 ssed in the SVZ, and transgenic mice lacking tenascin C show delayed acquisition of the EGF receptor.
232                                 Mice lacking tenascin-C show attenuation of skin and lung fibrosis, a
233   Here we show that mice that do not express tenascin-C show rapid resolution of acute joint inflamma
234  we show that the regenerative ECM component tenascin-C significantly increases newt cardiomyocyte ce
235 erexpressed the largest but not the smallest tenascin-C splice variant when given a choice between co
236  as indicated by inappropriate expression of tenascin-C starting by day 6 of pregnancy.
237                                    Exogenous tenascin-C stimulates collagen gene expression and myofi
238 he desmoplastic extracellular matrix protein tenascin C, suppressing tumor outgrowth, and improving h
239 e utilized the extracellular matrix molecule tenascin-C (tenascin) and an antibody (Ab) to the cell a
240 born cells were three times more adherent to tenascin-C than adult cells.
241               Here we map three sites within tenascin-C that directly and cooperatively interact with
242 llular deposits of eosinophil peroxidase and tenascin C, the effects not seen with placebo.
243 taining the fibronectin type III domain D of tenascin C, the long NC3 isoform of collagen type XII, t
244 e effective than laminin-1, L1-Fc, or intact tenascin-C, thus demonstrating the potential applicabili
245                     For cyclinD1, fibulin 2, tenascin C, TIMP1, and aquaporin-4, correlations were si
246                                              Tenascin-C (TN) is an extracellular matrix protein that
247                       Enhanced expression of tenascin-C (TN-C) at the invasive edges of glioblastoma
248 Intense matrix metalloproteinase (MMP-2) and tenascin-C (TN-C) expression were seen in the proximity
249 h vascular disease, colocalizing to sites of tenascin-C (TN-C) expression.
250           To determine the potential role of tenascin-C (TN-C) in the pathophysiology of atherosclero
251                                              Tenascin-C (TN-C) is an extracellular matrix (ECM) prote
252                                              Tenascin-C (TN-C) is an extracellular matrix protein tha
253                                              Tenascin-C (TN-C) is expressed in embryogenesis, tissue
254      To address this question, we focused on tenascin-C (TN-C), a stromal extracellular matrix glycop
255 icipates in network formation, we focused on tenascin-C (TN-C), an extracellular matrix (ECM) protein
256 dy was performed to test the hypothesis that tenascin-C (TN-C), an extracellular matrix (ECM) protein
257                                              Tenascin-C (TN-C), an extracellular matrix glycoprotein
258    PDGF-BB also stimulates the expression of tenascin-C (TN-C), an extracellular matrix glycoprotein
259 vation of FAK and cellular interactions with tenascin-C (TN-C).
260 ed the expression of the profibrotic factors tenascin C (TNC) and connective tissue growth factor (CT
261                                              Tenascin C (TNC) is a matricellular glycoprotein whose e
262 catenin signaling led to marked induction of tenascin C (TNC), an established promoter of cancer meta
263  of multiple metastasis effectors, including Tenascin C (Tnc), Jagged1 (Jag1), and Epiregulin (Ereg).
264 ranscriptional regulation of the ECM protein tenascin C (Tnc), which was necessary and sufficient for
265 ), mapped within the gene coding sequence of Tenascin C (TNC).
266  metastasis-initiating ability by expressing tenascin C (TNC).
267 ctive tissue growth factor (Ctgf, P = 0.04), tenascin C (Tnc, P = 0.035), Collagen Ialpha1 (Col1a1, P
268 tified the extracellular matrix glycoprotein tenascin-C (TNC) as an important regulator of ENCC devel
269 o determine the temporospatial expression of tenascin-C (TnC) in balloon-injured rat and porcine arte
270 pattern of the extracellular matrix molecule tenascin-C (Tnc) in the developing mouse olfactory bulb
271                                              Tenascin-C (TNC) is a highly conserved matricellular pro
272                                              Tenascin-C (TNC) is a mechano-regulated, morphogenic, ex
273                                              Tenascin-C (Tnc) is an extracellular matrix protein (ECM
274                                              Tenascin-C (TNC) is highly expressed in melanoma; howeve
275 r mPIN used the extracellular matrix protein Tenascin-C (TNC) to inhibit T-cell receptor-dependent T-
276                Here we provide evidence that tenascin-C (TNC), an extracellular matrix protein promin
277                                              Tenascin-C (TnC), an extracellular matrix protein, is tr
278 ral S100 proteins, including Fibronectin and Tenascin-C (Tnc), in primary lung tumors and associated
279                                              Tenascin-C (TNC), overexpressed in invasive growths, has
280 or alpha-smooth muscle actin (alpha-SMA) and tenascin-C (TNC).
281 y HIV-1-neutralizing protein in breast milk, Tenascin-C (TNC).
282 th at least three members: tenascin-X (TNX), tenascin-C (TNC, or cytotactin) and tenascin-R (TN-R, or
283 ne signature identified five common targets: tenascin-C(TNC), matrix metalloprotease-2, collagen-6-A1
284 ctin (fnFN10) and the 3rd FN-III domain from tenascin-C (tnFN3) have 27% sequence identity and the sa
285 EDGIHELFP(48)) resembles the sequence within tenascin-C to which the integrin alpha(9)beta(1) binds.
286 nD to an eight amino acid sequence unique to tenascin-C, VFDNFVLK, and showed that the amino acids FD
287 ha-smooth muscle actin were reduced, whereas tenascin C was increased, suggesting that P15-1 promoted
288 sis of PAH such as serotonin transporter and tenascin-C was elevated in distal arteries and had a hig
289 Fibroblast response to fibulin-1, similar to tenascin-C, was dependent on expression of the heparan s
290  aptamer to the extracellular matrix protein tenascin-C, was prepared in fluorescent and radiolabeled
291 nction relationships of different domains of tenascin-C, we used recombinant full-length fibronectin-
292 remodeling such as MMP-9, procollagen-3, and tenascin C were observed in all acute eczematous lesions
293 Increased apoptosis and immunoreactivity for tenascin-C were observed in mutant muscle fibers.
294 istribution of molecular markers (SHH, NCAM, Tenascin-C) were characteristic of feather buds.
295 pha-smooth muscle actin (SMA), vimentin, and tenascin-c, were measured in archived human HCC tissues
296 ar degeneration-affected Bruch's membrane is tenascin-C which we confirm is present at high levels in
297 ulation of the extracellular matrix protein, tenascin C, which affords a scaffold for VSMC migration.
298               Calcific leaflets also exhibit tenascin-C, which may facilitate inflammatory cell migra
299 nderstanding the mechanism of interaction of tenascin-C with smooth muscle cells and a framework for
300 milarity with the fibrinogen domain of human tenascin-C, with a human C-type serum lectin, and with p

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top